Cite
HARVARD Citation
Toussirot, E. et al. (2017). Switching from originator biological agents to biosimilars: what is the evidence and what are the issues?. RMD open. 3 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toussirot, E. et al. (2017). Switching from originator biological agents to biosimilars: what is the evidence and what are the issues?. RMD open. 3 (2), p. . [Online].